Pathstone Holdings LLC Trims Position in The Clorox Company (NYSE:CLX)

Pathstone Holdings LLC lowered its position in The Clorox Company (NYSE:CLX) by 3.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,040 shares of the company’s stock after selling 427 shares during the quarter. Pathstone Holdings LLC’s holdings in Clorox were worth $2,124,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Aviance Capital Partners LLC grew its stake in shares of Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock valued at $502,000 after buying an additional 80 shares during the period. Baron Wealth Management LLC purchased a new position in Clorox in the third quarter worth approximately $250,000. Cassaday & Co Wealth Management LLC acquired a new stake in Clorox during the third quarter worth $231,000. Mendel Capital Management LLC raised its position in Clorox by 8.9% in the third quarter. Mendel Capital Management LLC now owns 3,261 shares of the company’s stock valued at $531,000 after purchasing an additional 267 shares during the period. Finally, MAI Capital Management lifted its stake in shares of Clorox by 2.1% in the 3rd quarter. MAI Capital Management now owns 12,918 shares of the company’s stock valued at $2,104,000 after purchasing an additional 260 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.57% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $167.34 on Wednesday. The business has a 50-day simple moving average of $162.84 and a 200-day simple moving average of $148.88. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a one year low of $127.60 and a one year high of $171.35. The company has a market cap of $20.71 billion, a PE ratio of 58.31, a P/E/G ratio of 3.13 and a beta of 0.41.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the firm posted $0.49 EPS. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. On average, equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is 170.03%.

Analysts Set New Price Targets

Several analysts recently issued reports on CLX shares. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and boosted their price objective for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Citigroup upped their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Finally, DA Davidson lifted their price objective on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.